APA (7th ed.) Citation

Clerico, M., Faggiano, F., Palace, J., Rice, G., Tintorè, M., & Durelli, L. (2008). Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

Chicago Style (17th ed.) Citation

Clerico, M., F. Faggiano, J. Palace, G. Rice, M. Tintorè, and L. Durelli. Recombinant Interferon Beta or Glatiramer Acetate for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis. 2008.

MLA (9th ed.) Citation

Clerico, M., et al. Recombinant Interferon Beta or Glatiramer Acetate for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis. 2008.

Warning: These citations may not always be 100% accurate.